These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 15568188)

  • 1. Determination of the optimal sample size for a clinical trial accounting for the population size.
    Stallard N; Miller F; Day S; Hee SW; Madan J; Zohar S; Posch M
    Biom J; 2017 Jul; 59(4):609-625. PubMed ID: 27184938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha spending for historical versus surveillance Poisson data with CMaxSPRT.
    Silva IR; Lopes WM; Dias P; Yih WK
    Stat Med; 2019 May; 38(12):2126-2138. PubMed ID: 30689224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution.
    Shipes VB; Meinzer C; Wolf BJ; Li H; Carpenter MJ; Kamel H; Martin RH
    Stat Med; 2023 Dec; 42(30):5694-5707. PubMed ID: 37926516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter in response to: "The importance of clinical importance when determining the target difference in sample size calculations".
    Wong H
    Trials; 2023 Oct; 24(1):666. PubMed ID: 37828523
    [No Abstract]   [Full Text] [Related]  

  • 5. Study design for restricted mean time analysis of recurrent events and death.
    Mao L
    Biometrics; 2023 Dec; 79(4):3701-3714. PubMed ID: 37612246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A joint model for recurrent events and a semi-competing risk in the presence of multi-level clustering.
    Jung TH; Peduzzi P; Allore H; Kyriakides TC; Esserman D
    Stat Methods Med Res; 2019; 28(10-11):2897-2911. PubMed ID: 30062911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome.
    Chen MH; Ibrahim JG; Zeng D; Hu K; Jia C
    Biometrics; 2014 Dec; 70(4):1003-13. PubMed ID: 25041037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights on the robust variance estimator under recurrent-events model.
    Al-Khalidi HR; Hong Y; Fleming TR; Therneau TM
    Biometrics; 2011 Dec; 67(4):1564-72. PubMed ID: 21418051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust covariate-adjusted log-rank statistics and corresponding sample size formula for recurrent events data.
    Song R; Kosorok MR; Cai J
    Biometrics; 2008 Sep; 64(3):741-750. PubMed ID: 18162107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
    Daimon T
    Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistics in review. Part 2: generalised linear models, time-to-event and time-series analysis, evidence synthesis and clinical trials.
    Moran JL; Solomon PJ
    Crit Care Resusc; 2007 Jun; 9(2):187-97. PubMed ID: 17536991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size calculations for comparative clinical trials with over-dispersed Poisson process data.
    Matsui S
    Stat Med; 2005 May; 24(9):1339-56. PubMed ID: 15568188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event.
    Li B; Grambsch P
    Clin Trials; 2006; 3(4):349-59. PubMed ID: 17060209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-inferiority trial design for recurrent events.
    Cook RJ; Lee KA; Li H
    Stat Med; 2007 Nov; 26(25):4563-77. PubMed ID: 17380542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size calculations for the two-sample problem using the multiplicative intensity model.
    Bernardo MV; Harrington DP
    Stat Med; 2001 Feb; 20(4):557-79. PubMed ID: 11223901
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.